Stockscreener 앱 받기
4.39
5.78%
0.24
시간 외 거래:
4.45
0.06
+1.37%
전일 마감가:
$4.15
열려 있는:
$4.19
하루 거래량:
287.73K
Relative Volume:
0.57
시가총액:
$463.07M
수익:
$45.44M
순이익/손실:
$-35.43M
주가수익비율:
-12.91
EPS:
-0.34
순현금흐름:
$-25.39M
1주 성능:
+6.30%
1개월 성능:
+22.63%
6개월 성능:
+16.76%
1년 성능:
-0.68%
1일 변동 폭
$4.18
$4.475
1주일 범위
$4.015
$4.475
52주 변동 폭
$3.165
$5.545
맥스사이트 Stock (MXCT) Company Profile
명칭
Maxcyte Inc
전화
301-517-5556
주소
9713 KEY WEST AVENUE,, ROCKVILLE
MXCT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MXCT
Maxcyte Inc
|
4.39 | 463.07M | 45.44M | -35.43M | -25.39M | -0.34 |
|
ABT
Abbott Laboratories
|
113.83 | 197.43B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
361.52 | 137.82B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
90.69 | 133.66B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
80.95 | 103.80B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
73.91 | 43.59B | 6.60B | 4.16B | 490.10M | 6.93 |
맥스사이트 Stock (MXCT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-11-29 | 개시 | Craig Hallum | Buy |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-08-24 | 개시 | BTIG Research | Buy |
| 2021-08-24 | 개시 | Cowen | Outperform |
| 2021-08-24 | 개시 | Stephens | Overweight |
| 2021-08-24 | 개시 | Stifel | Buy |
| 2021-08-24 | 개시 | Wedbush | Outperform |
| 2021-08-24 | 개시 | William Blair | Outperform |
모두보기
맥스사이트 주식(MXCT)의 최신 뉴스
MaxCyte Expands Common Stock Issuance to 105.7 Million Shares - TipRanks
Franklin Resources Inc. Makes New Investment in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
Geode Capital Management LLC Grows Holdings in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
Barclays PLC Grows Stock Holdings in MaxCyte, Inc. (NASDAQ:MXCT) - MarketBeat
Barclays PLC Grows Holdings in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
MaxCyte director sells shares after option exercise By Investing.com - Investing.com South Africa
Art Mandell Retires from MaxCyte Board - citybiz
MaxCyte director sells shares after option exercise - Investing.com India
Maxcyte director Johnston sells shares worth $12,020 - Investing.com India
MaxCyte Director Exercises Stock Options and Executes Sales - TipRanks
Maxcyte director Johnston sells shares worth $12,020 By Investing.com - Investing.com Australia
MaxCyte, Inc. (NASDAQ:MXCT) Director Sells $12,030.00 in Stock - MarketBeat
MaxCyte Announces Leadership Transition and Strategic Focus - MSN
State Street Corp Grows Stake in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
MaxCyte Streamlines Workforce and Boosts Revenue Outlook - MSN
MaxCyte, Inc. Announces Retirement of Board Member Art Mandell - Marketscreener.com
MaxCyte board member Art Mandell retires - Investing.com India
MaxCyte board member Art Mandell retires By Investing.com - Investing.com Canada
MaxCyte Announces Retirement of Board Member Art Mandell - The Manila Times
MaxCyte Announces Board Member Retirement - TipRanks
MaxCyte Board Member Art Mandell to Exit After 18-Year Tenure Marked by Landmark CRISPR Achievements - StockTitan
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 27,111 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
MaxCyte Announces Change in Shareholder Voting Rights Due to BlackRock Holdings - TipRanks
BlackRock Adjusts Stake in MaxCyte, Influencing Voting Rights - TipRanks
MaxCyte (LON:MXCT) Shares Up 3.4%Here's Why - MarketBeat
MaxCyte (LON:MXCT) Shares Up 3.4% – Here’s Why - Defense World
Fmr LLC Lowers Stake in MaxCyte, Inc. (NASDAQ:MXCT) - MarketBeat
MaxCyte cuts 15% of global workforce, boosts core revenue guidance - MSN
MaxCyte, Inc. Announces Change in Major Holdings by BlackRock - TipRanks
MaxCyte Announces Change in Major Shareholdings - TipRanks
Getting In Cheap On MaxCyte, Inc. (LON:MXCT) Might Be Difficult - Simply Wall St
MaxCyte Shares Surge On Boost to Revenue-Growth Outlook - MarketWatch
MaxCyte ups core revenue guidance for 2024 as eyes 2025 cost savings - Marketscreener.com
MaxCyte Announces Streamlined Operations and Raises 2024 Revenue Guidance Provide Update - citybiz
MaxCyte Inc slashes workforce by 15%, ups revenue forecast - TradingPedia
MaxCyte upgrades revenue guidance after operational review - ShareCast
MXCTMaxCyte, Inc. Latest Stock News & Market Updates - StockTitan
Intech Investment Management LLC Purchases New Shares in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
MaxCyte Announces Streamlined Operations and Raises 2024 Revenue Guidance - The Manila Times
MaxCyte cuts 15% of global workforce, boosts core revenue guidance (NASDAQ:MXCT) - Seeking Alpha
MaxCyte Restructures with 15% Job Cuts, Boosts 2024 Revenue Growth Outlook to 8% - StockTitan
ArrowMark Colorado Holdings LLC Purchases 169,250 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - MarketBeat
MaxCyte Expands Stock Capital Amid Cell Therapy Growth - TipRanks
MaxCyte Sees Shift in BlackRock’s Shareholding - MSN
MaxCyte’s Voting Rights Shift with BlackRock Acquisition - MSN
MaxCyte, Inc. (NASDAQ:MXCT) Shares Purchased by Mudita Advisors LLP - MarketBeat
맥스사이트 (MXCT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.82%
자본화:
|
볼륨(24시간):